Assessing adverse reactions in people living with epilepsy on levetiracetam

• Neurological Adverse Drug reaction is common in patients with epilepsy. • Seizure's lower age of onset is associated with adverse drug reactions. • Higher Liverpool Adverse Event Profile scores were significantly associated with adverse drug reactions. • Healthcare providers should focus on identifying and mitigating these adverse drug reactions to improve the quality of care in Patients with epilepsy. This study aimed to evaluate factors associated with adverse drug reaction (ADR) among people with epilepsy (PWE) on Levetiracetam (LEV) monotherapy. This descriptive, cross-sectional study, utilized a total purposive sampling method, to recruit 102 consenting participants on LEV monotherapy. Seizure classification was determined using the 2017 International League against Epilepsy (ILAE) guideline. Liverpool Adverse Events Profile (LAEP) was employed to evaluate ADR in individuals on LEV monotherapy. There were 44 (43%) had ADR [single 21(20.59%) vs multiple 23(22.55%)], while 58 (56.86%) had No Adverse Drug Reaction (NADR) respectively. The most common ADRs were headaches 20 (19.6%), disturbed sleep (18.6%), and dizziness 16 (15.7%). Demographic and clinical characteristics were comparable among ADR, and NADR, except for marital status (p0.043), lower age at onset [23.89 ± 13.30 vs 32.32 ± 20.34 (p0.027)], and higher LAEP score [24.48 ± 5.55 vs 19.00 ± 0.00 (p<0.001)]. The parameters were also comparable in single and multiple reactions except for marital status (p0.035), and etiology (p0.012). Furthermore, lower age at onset (p0.027), and higher LAEP score (p<0.001) were identified factors associated with ADR among participants. However, none of these predicted ADR. Nearly half of the participants had ADR, with neurological ADRs being the commonest, and 23% of them had multiple ADRs. Furthermore, lower age at onset and higher LAEP scores were significantly associated with ADR. Healthcare providers should focus on identifying and mitigating these ADRs to improve the quality of care in PWE.

Authors

Institutions

Publication Details

Journal
Brain Disorders
Published
2025-08-22
DOI
https://doi.org/10.1016/j.dscb.2025.100273
Citations
1
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
1.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessing adverse reactions in people living with epilepsy on levetiracetam

Ibironke Oyenuga, Luqman Ogunjimi, Emmanuel S. Irokosu, Bamidele Osalusi et al.
1 citations
Brain Disorders
Epilepsy research and treatment
1.47
article

Assessing adverse reactions in people living with epilepsy on levetiracetam

Ibironke Oyenuga, Luqman Ogunjimi, Emmanuel S. Irokosu, Bamidele Osalusi, Bolanle Falujo, Yahya-Imam Abdul-Kabir Adegoke, Fehintola Fatai, Aderonke Aderinola, Damilola Ogungbemi, Oluwatobiloba Oluseyije, Akinyinka Alabi, Fedora Ojini, Abdullahi Murtala, Latifat ELEGBEDE, Ayomide OLADIPUPO, Doyinsola OMILANA, Uka Aaron
article en
1 citations

Abstract

• Neurological Adverse Drug reaction is common in patients with epilepsy. • Seizure's lower age of onset is associated with adverse drug reactions. • Higher Liverpool Adverse Event Profile scores were significantly associated with adverse drug reactions. • Healthcare providers should focus on identifying and mitigating these adverse drug reactions to improve the quality of care in Patients with epilepsy. This study aimed to evaluate factors associated with adverse drug reaction (ADR) among people with epilepsy (PWE) on Levetiracetam (LEV) monotherapy. This descriptive, cross-sectional study, utilized a total purposive sampling method, to recruit 102 consenting participants on LEV monotherapy. Seizure classification was determined using the 2017 International League against Epilepsy (ILAE) guideline. Liverpool Adverse Events Profile (LAEP) was employed to evaluate ADR in individuals on LEV monotherapy. There were 44 (43%) had ADR [single 21(20.59%) vs multiple 23(22.55%)], while 58 (56.86%) had No Adverse Drug Reaction (NADR) respectively. The most common ADRs were headaches 20 (19.6%), disturbed sleep (18.6%), and dizziness 16 (15.7%). Demographic and clinical characteristics were comparable among ADR, and NADR, except for marital status (p0.043), lower age at onset [23.89 ± 13.30 vs 32.32 ± 20.34 (p0.027)], and higher LAEP score [24.48 ± 5.55 vs 19.00 ± 0.00 (p<0.001)]. The parameters were also comparable in single and multiple reactions except for marital status (p0.035), and etiology (p0.012). Furthermore, lower age at onset (p0.027), and higher LAEP score (p<0.001) were identified factors associated with ADR among participants. However, none of these predicted ADR. Nearly half of the participants had ADR, with neurological ADRs being the commonest, and 23% of them had multiple ADRs. Furthermore, lower age at onset and higher LAEP scores were significantly associated with ADR. Healthcare providers should focus on identifying and mitigating these ADRs to improve the quality of care in PWE.

Brain DisordersVol. 19
University of Ibadan (NG), Babcock University (NG), Olabisi Onabanjo University (NG)
Openalex Percentile: Top 16%
Epilepsy research and treatment
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.